• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

SUPPLEMENTAL ABBREVIATED NEW ANIMAL DRUG APPROVALS - July/August 1999

FDA Veterinarian Newsletter July/August 1999 Volume XIV, No IV

CompanyGeneric & (Brand) NamesIndicationsRoutes/Remarks
Boehringer Ingelheim Vetmedica, Inc. (ANADA 200-008)Oxytetracycline (OxytetTM 200) (Bio-Mycin® 200)Cattle, swine. In beef and nonlactating dairy cattle for treatment of bacterial pneumonia, shipping fever, pinkeye, foot rot, diphtheria, bacterial enteritis, wooden tongue, leptospirosis, wound infections, acute metritis. In swine for treatment of bacterial enteritis.SUBCUTANEOUS AND INTRAMUSCULAR: The ANADA provides for a 28-day withdrawal period for subcutaneous use of oxytetracycline in cattle and for intramuscular use in swine.
Federal Register: 05/17/99.